The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 47-52 , January 2010

Controlled Clinical Trial Assessing the Effect of Laparoscopic Uterine Arterial Occlusion on Ovarian Reserve

Received 1 May 2009 ,Accepted 1 October 2009.

References 

  1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94:435–438
  2. Cheng Z, Yang W, Dai H, et al. Laparoscopic uterine artery occlusion combined with myomectomy for uterine myomas. J Minim Invasive Gynecol. 2008;15:346–349
  3. Hurst BS, Matthews ML, Marshburn PB, et al. Laparoscopic myomectomy for symptomatic uterine myomas. Fertil Steril. 2005;83:1–23
  4. Semm K. Hysterectomy via laparotomy or pelviscopy: a new CASH method without colpotomy. Geburshilfe Frauenheilkd. 1991;51:996–1003
  5. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arteral embolization to treat uterine fibroidta. Lancet. 1995;346:671–672
  6. Scheurig C, Gauruder A, Kluner C, et al. Uterine artery embolizatron for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Hum Reprod. 2006;21:3270–3277
  7. Liu WM, Ng HT, Wu YC, et al. Laparoscopic bipolar coagulation of uterine vessels: a new method for treating symptomatic fibroids. Fertil Steril. 2001;75:417–422
  8. Hald K, Klow NE, Qvigstad E, et al. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstet Gynecol. 2007;109:20–27
  9. Holub Z, Eim J, Jabor A, et al. Complications and myoma recurrence after laparoscopic uterine artery occlusion for symptomatic myomas. J Obstet Gynecol Res. 2006;32:55–62
  10. Lui WM, Wang PH, Chou CS, et al. Efficacy of combined laparoscopic uterine artery occlusion and myomectomy via minilaparotomy in the treatment of recurrent uterine myomas. Fertil Steril. 2007;87:356–361
  11. Cheng Z, Xie Y, Dai H, Hu L, Zhu Y, Gong J. Unequal tissue expression of proteins from the PA/PAI system, myoma necrosis, and uterus survival after uterine artery occlusion. Int J Gynaecol Obstet. 2008;102:55–59
  12. Penarrubia J, Balasch J, Fábregues F, et al. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin releasing hormone agonist gonadotrophin treatment. Hum Reprod. 2000;15(7):1499–1504
  13. Fawzy M, Lambert A, Harrison RF, et al. Day 5 inhibin B concentrations in a treatment cycle are predictive of IVF outcome. Hum Reprod. 2002;17:1535–1543
  14. Lambert GM, Harlow BL. The influence of depression, body mass index, and smoking on serum inhibin B concentrations in late reproductive-aged women. J Clin Endocrinol Metab. 2006;91:1496–1500
  15. Amer SA, Laird S, Ledger WL, et al. Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with a novulatory polycystic ovary syndrome. Hum Reprod. 2007;22:389–394
  16. Nikolic B, Spies JB, Lundsten MJ, et al. Patient radiation dose associated with uterine artery embolization. Radiology. 2000;214:121–125
  17. Van Rooij IA, Bancsi LF, Broekmans FJ, et al. Women older than 40 years of age and those with elevated follicle-stimulating hormone concentrations differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril. 2003;79:482–488
  18. Ho JY, Guu HF, Yi YC, et al. The serum follicle-stimulating hormone–to–luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict “low responders”. Fertil Steril. 2005;83:883–888

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(09)01137-6

doi: 10.1016/j.jmig.2009.10.001

The Journal of Minimally Invasive Gynecology
Volume 17, Issue 1 , Pages 47-52 , January 2010

Article Tools